Gender |
|
|
Male |
54.8% |
23/42 |
Female |
45.2% |
19/42 |
Indifferent |
0% |
0/42 |
Unknown |
0% |
0/42 |
General |
|
|
Birth Length abnormalities |
0% |
0/41 |
Birth Weight abnormalities |
0% |
0/41 |
Birth Head circumference abnormalities |
2.5% |
1/40 |
< P3 : Congenital microcephaly |
2.5% |
1/40 |
Current Height abnormalities |
7.1% |
3/42 |
> P98 : Tall stature |
7.1% |
3/42 |
Current Weight abnormalities |
4.9% |
2/41 |
> P98 : Increased body weight |
4.9% |
2/41 |
Current Head circumference abnormalities |
9.8% |
4/41 |
> P98 : Macrocephaly |
7.3% |
3/41 |
< P3 : Microcephaly |
2.4% |
1/41 |
Neurology |
|
|
Neurological abnormalities |
90.2% |
37/41 |
Sleep disturbance |
46.3% |
19/41 |
Seizures |
43.9% |
18/41 |
Poor eye contact |
39.0% |
16/41 |
Muscular hypotonia |
34.1% |
14/41 |
Gait ataxia |
14.6% |
6/41 |
Absence seizures |
9.8% |
4/41 |
Gait disturbance |
7.3% |
3/41 |
Insomnia |
7.3% |
3/41 |
Central hypotonia |
4.9% |
2/41 |
Generalized tonic-clonic seizures |
4.9% |
2/41 |
Absent speech |
2.4% |
1/41 |
Bruxism |
2.4% |
1/41 |
Dystonia |
2.4% |
1/41 |
Easy fatigability |
2.4% |
1/41 |
EEG abnormality |
2.4% |
1/41 |
EEG with persistent abnormal rhythmic activity |
2.4% |
1/41 |
EEG with generalized epileptiform discharges |
2.4% |
1/41 |
Epileptic encephalopathy |
2.4% |
1/41 |
Episodic generalized hypotonia |
2.4% |
1/41 |
Focal seizures |
2.4% |
1/41 |
Generalized seizures |
2.4% |
1/41 |
Generalized hypotonia |
2.4% |
1/41 |
Global developmental delay |
2.4% |
1/41 |
Headache |
2.4% |
1/41 |
Intellectual disability, progressive |
2.4% |
1/41 |
Muscle weakness |
2.4% |
1/41 |
Poor fine motor coordination |
2.4% |
1/41 |
Ptosis |
2.4% |
1/41 |
Severe muscular hypotonia |
2.4% |
1/41 |
Status epilepticus |
2.4% |
1/41 |
Tip-toe gait |
2.4% |
1/41 |
Tremor |
2.4% |
1/41 |
Behavioral problems |
92.9% |
39/42 |
Autism |
61.9% |
26/42 |
Mood swings |
47.6% |
20/42 |
Impaired pain sensation |
38.1% |
16/42 |
Aggressive behavior |
31.0% |
13/42 |
Autistic behavior |
9.5% |
4/42 |
Stereotypic behavior |
9.5% |
4/42 |
Pain insensitivity |
7.1% |
3/42 |
Agitation |
4.8% |
2/42 |
Attention deficit hyperactivity disorder |
4.8% |
2/42 |
Hyperactivity |
4.8% |
2/42 |
Irritability |
4.8% |
2/42 |
Punding |
4.8% |
2/42 |
Self-injurious behavior |
4.8% |
2/42 |
Anxiety |
2.4% |
1/42 |
Delayed speech and language development |
2.4% |
1/42 |
Inappropriate laughter |
2.4% |
1/42 |
Low frustration tolerance |
2.4% |
1/42 |
Motor delay |
2.4% |
1/42 |
Oppositional defiant disorder |
2.4% |
1/42 |
Polyphagia |
2.4% |
1/42 |
Psychosis |
2.4% |
1/42 |
Brain abnormality |
34.4% |
11/32 |
EEG abnormality |
18.8% |
6/32 |
Abnormal brainstem MRI signal intensity |
3.1% |
1/32 |
Aplasia/Hypoplasia of the cerebral white matter |
3.1% |
1/32 |
Aplasia/Hypoplasia of the corpus callosum |
3.1% |
1/32 |
Arachnoid cyst |
3.1% |
1/32 |
Cerebral ischemia |
3.1% |
1/32 |
Cortical dysplasia |
3.1% |
1/32 |
Macrocephaly |
3.1% |
1/32 |
Facial abnormalities |
|
|
Abnormality of the ear |
3.0% |
1/33 |
Bifid tragus |
3.0% |
1/33 |
Abnormality of the eye |
18.2% |
6/33 |
Horizontal eyebrow |
9.1% |
3/33 |
Deeply set eye |
3.0% |
1/33 |
Epicanthus |
3.0% |
1/33 |
Hypertelorism |
3.0% |
1/33 |
Upslanted palpebral fissure |
3.0% |
1/33 |
Abnormality of the nose |
17.6% |
6/34 |
Prominent nasal tip |
8.8% |
3/34 |
Broad nasal tip |
2.9% |
1/34 |
Depressed nasal bridge |
2.9% |
1/34 |
Abnormality of the mouth |
29.4% |
10/34 |
Exaggerated cupid's bow |
11.8% |
4/34 |
Thick lower lip vermilion |
11.8% |
4/34 |
Open mouth |
5.9% |
2/34 |
Abnormality of mouth shape |
2.9% |
1/34 |
Absent cupid's bow |
2.9% |
1/34 |
Ankyloglossia |
2.9% |
1/34 |
High palate |
2.9% |
1/34 |
Prominence of the premaxilla |
2.9% |
1/34 |
Widely spaced teeth |
2.9% |
1/34 |
Visual and hearing impairments |
|
|
Abnormal hearing |
6.3% |
2/32 |
Hearing impairment |
6.3% |
2/32 |
Abnormal vision |
23.3% |
7/30 |
Strabismus |
10.0% |
3/30 |
Astigmatism |
3.3% |
1/30 |
Exotropia |
3.3% |
1/30 |
Hyperopic astigmatism |
3.3% |
1/30 |
Myopia |
3.3% |
1/30 |
Heart |
|
|
Abnormality of the heart |
2.9% |
1/35 |
Pulmonary hypertension |
2.9% |
1/35 |
Secundum atrial septal defect |
2.9% |
1/35 |
Gastrointestinal |
|
|
Gastrointestinal abnormalities |
61.1% |
22/36 |
Feeding difficulties |
25.0% |
9/36 |
Constipation |
22.2% |
8/36 |
Gastroesophageal reflux |
22.2% |
8/36 |
Cow milk allergy |
8.3% |
3/36 |
Diarrhea |
8.3% |
3/36 |
Chronic constipation |
5.6% |
2/36 |
Intermittent diarrhea |
5.6% |
2/36 |
Chronic diarrhea |
2.8% |
1/36 |
Failure to thrive |
2.8% |
1/36 |
Feeding difficulties in infancy |
2.8% |
1/36 |
Gastrointestinal inflammation |
2.8% |
1/36 |
Urogenital |
|
|
Abnormality of the urogenital system |
5.6% |
2/36 |
Bilateral cryptorchidism |
2.8% |
1/36 |
Prominent scrotal raphe |
2.8% |
1/36 |
Skeleton |
|
|
Skeletal abnormalities |
62.2% |
23/37 |
Joint hypermobility |
24.3% |
9/37 |
Prominent fingertip pads |
21.6% |
8/37 |
Abnormality of limbs |
16.2% |
6/37 |
2-3 toe syndactyly |
8.1% |
3/37 |
Kyphoscoliosis |
5.4% |
2/37 |
Sacral dimple |
5.4% |
2/37 |
Large hands |
2.7% |
1/37 |
Pectus excavatum |
2.7% |
1/37 |
Pes planus |
2.7% |
1/37 |
Scoliosis |
2.7% |
1/37 |
Short finger |
2.7% |
1/37 |
Short fourth metatarsal |
2.7% |
1/37 |
Splayed toes |
2.7% |
1/37 |
2-3 toe cutaneous syndactyly |
2.7% |
1/37 |
Skin / Hair / Nails |
|
|
Abnormality of the skin/hair/nails |
32.4% |
12/37 |
Fair hair |
13.5% |
5/37 |
Fine hair |
10.8% |
4/37 |
Abnormality of the fingernails |
2.7% |
1/37 |
Aplasia/Hypoplasia of the nails |
2.7% |
1/37 |
Dry skin |
2.7% |
1/37 |
Eczematoid dermatitis |
2.7% |
1/37 |
Eczema |
2.7% |
1/37 |
Hemangioma |
2.7% |
1/37 |
Nail dystrophy |
2.7% |
1/37 |
Thick hair |
2.7% |
1/37 |
Endocrine / Immunological / Metabolic |
|
|
Abnormality of the endocrine system |
3.8% |
1/26 |
Dysharmonic delayed bone age |
3.8% |
1/26 |
Abnormality of the immune system |
42.9% |
15/35 |
Recurrent infections |
28.6% |
10/35 |
Recurrent infections in infancy and early childhood |
8.6% |
3/35 |
Conjunctivitis |
2.9% |
1/35 |
Esophagitis |
2.9% |
1/35 |
Recurrent otitis media |
2.9% |
1/35 |